Ritonavir CAS 155213-67-5 in the treatment of advanced or non-progressive AIDS 

Ritonavir Profile

Product Name: Ritonavir 

Synonyms: 1,3-thiazol-5-ylmethyl n-[(2s,3s,5r)-3-hydroxy-5-[[(2s)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenyl-hexan-2-yl]carbamate;1,3-THIAZOL-5-YLMETHANOL;CHEMBRDG-BB 4050354;THIAZOL-5-YL-METHANOL;RITONAVIR;RARECHEM AL BD 1261;ABT-538;Liponavir Core 

CAS: 155213-67-5 

MF: C37H48N6O5S2 

MW: 720.96 

EINECS: 208-127-9 

Product Categories: Anti-AIDS;Sulphur Derivatives;Active Pharmaceutical Ingredients;Anti-viral Compounds;Anti-virals;Inhibitors;Intermediates & Fine Chemicals;Non-nucleoside Reverse Transcriptase;Pharmaceuticals;Steroids;HIV/AIDS/Related Products;Inhibitor;peptides;NORVIR;API 

Mol File: 155213-67-5.mol 

Melting point  120-122°C 

storage temp.  -20°C Freezer 

Chemical Properties: White Powder 

Usage A selective HIV protease inhibitor 

Purity:99%

Package:25kg/barrel or as your inquiry

Shelf life:2 years

Standard:Enterprise Standard 

Price:negotiable 

MOQ:10g

Specification:ISO9001,USP,BP

Trade Mark:CQSP

Port:Shenzhen/Shanghai,China

Production Capacity:5000kg/month

Shipping: FedEx, DHL, EMS, TNT, HK EMS, Eub, Etk

Payment: Western Union, Moneygram, T/T, Bitcoin

Delivery time: Parcel can be sent out within 24 hours after payment,4-7days to arrive.

More details pls contact:Whatapp:86 13048470428  

 Skype/E-mail : summer at chembj.com

Ritonavir Description

Ritonavir is an orally potent inhibitor of human immunodeficiency virus-1 (HIV-1) and human immunodeficiency virus-2 (HIV-2) aspartic protease, blocking the enzyme to produce morphologically mature HIV particles The required polyprotein, the HIV particles and thus remain in the immature state, thus slowing the spread of HIV in the cells to prevent a new round of infection and delay the development of disease. Ritonavir is well-tolerated against zidovudine-sensitive and zidovudine-resistant HIV strains.

Ritonavir Indications

Alone or in combination with antiretroviral nucleoside drugs in the treatment of advanced or non-progressive AIDS patients.